Carson Wealth (CWM LLC)
IGC icon

Carson Wealth (CWM LLC)’s IGC Pharma IGC Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$263 Buy
+1,000
New +$278 ﹤0.01% 5508

Other funds holding IGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
LC
Lawood & Co Williamsport, Pennsylvania $148M AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Carson Wealth (CWM LLC)'s IGC Position: Q1 2026 in Review

Carson Wealth (CWM LLC) opened a new position in IGC Pharma (IGC) in Q1 2026: 1,000 shares worth $263. The stake represents ﹤0.01% of the portfolio and ranks #5508 among its holdings.

35 funds tracked by Wall St. Rank hold IGC as of Q1 2026.

  • Carson Wealth (CWM LLC) held 1,000 shares of IGC Pharma worth $263 as of Q1 2026.
  • IGC Pharma was a new Carson Wealth (CWM LLC) position in Q1 2026.
  • IGC Pharma made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #5508 holding.
  • 35 funds tracked by Wall St. Rank held IGC Pharma as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.